home / stock / bcrx / bcrx quote
Last: | $4.38 |
---|---|
Change Percent: | -0.68% |
Open: | $4.44 |
Close: | $4.38 |
High: | $4.63 |
Low: | $4.37 |
Volume: | 4,233,769 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.38 | $4.44 | $4.38 | $4.63 | $4.37 | 4,233,769 | 04-23-2024 |
$4.41 | $4.43 | $4.41 | $4.57 | $4.39 | 2,557,483 | 04-22-2024 |
$4.43 | $4.5 | $4.43 | $4.59 | $4.27 | 4,693,501 | 04-19-2024 |
$4.5 | $4.6 | $4.5 | $4.71 | $4.49 | 2,959,857 | 04-18-2024 |
$4.58 | $4.65 | $4.58 | $4.79 | $4.57 | 4,055,194 | 04-17-2024 |
$4.61 | $4.61 | $4.61 | $4.72 | $4.54 | 1,979,399 | 04-16-2024 |
$4.67 | $4.78 | $4.67 | $4.785 | $4.59 | 2,496,660 | 04-15-2024 |
$4.77 | $5.1 | $4.77 | $5.16 | $4.7 | 4,525,575 | 04-12-2024 |
$5.1 | $4.93 | $5.1 | $5.115 | $4.82 | 3,304,258 | 04-11-2024 |
$4.87 | $4.64 | $4.87 | $4.905 | $4.56 | 2,915,235 | 04-10-2024 |
$4.8 | $4.61 | $4.8 | $4.88 | $4.61 | 1,973,613 | 04-09-2024 |
$4.61 | $4.62 | $4.61 | $4.67 | $4.54 | 1,604,592 | 04-08-2024 |
$4.6 | $4.56 | $4.6 | $4.66 | $4.45 | 1,784,555 | 04-05-2024 |
$4.6 | $4.76 | $4.6 | $4.84 | $4.58 | 2,736,551 | 04-04-2024 |
$4.73 | $4.71 | $4.73 | $4.7694 | $4.595 | 3,058,512 | 04-03-2024 |
$4.69 | $4.95 | $4.69 | $5.01 | $4.68 | 4,211,009 | 04-02-2024 |
$5.05 | $5.04 | $5.05 | $5.09 | $4.905 | 4,874,775 | 04-01-2024 |
$5.08 | $5.2 | $5.08 | $5.34 | $5.06 | 3,491,454 | 03-29-2024 |
$5.08 | $5.2 | $5.08 | $5.34 | $5.06 | 3,491,454 | 03-28-2024 |
$5.15 | $5.04 | $5.15 | $5.2075 | $4.97 | 2,990,374 | 03-27-2024 |
News, Short Squeeze, Breakout and More Instantly...
BioCryst Pharmaceuticals Inc. Company Name:
BCRX Stock Symbol:
NASDAQ Market:
BioCryst Pharmaceuticals Inc. Website:
RESEARCH TRIANGLE PARK, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company...
RESEARCH TRIANGLE PARK, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2024 financial results on Monday, May 6, 2024. BioCryst management will host a conference call and webcast a...
RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted approval for oral, once-daily ORLADEYO ® (berotralstat) for the prophylaxis of heredita...